At Investment-In-Innovation (IN3) Medical Device 360 Degrees Dublin, the Debate Will Continue: Should Medtech Companies Start-Up in the U.S. or Europe?
April 16-18, 2013, The Shelbourne Dublin
(firmenpresse) - DUBLIN, IRELAND -- (Marketwired) -- 04/08/13 -- , publisher of "The Gray Sheet" and the medtech industry's leading provider of strategic partnership and investment conferences, will host the partnering and investment conference on , at the . This special event will bring together a diverse group of medtech's key thought leaders from among corporate business development execs, family office, venture capital and angel investors, start-up entrepreneurs and industry pioneers. Program highlights will include:
Creating Value in European Healthcare: Transforming the Medtech Business Model to Deliver Value-Based Innovations: , President, Europe Middle East Africa and Canada (EMEAC), St. Jude Medical.
Given the challenges in raising capital for emerging medtech opportunities and getting regulatory approval, more and more U.S. companies are looking to develop and launch their products and start their companies in Europe; at the same time, the U.S. remains the largest medical device market in the world with the strongest infrastructure for small companies looking to build quickly. Further, most of the corporate exit decisions are taken in the U.S. offices of medtech strategics. So is the U.S. the best place to be? Or Europe? Or is it a question of building on the advantages that each region offers and getting the best of both? Factors that influence the decision include regulatory strategy, market size, etc. This session will explore the subject with executives from both geographies, each of whom has taken a different approach to that issue.
(moderator), Vice President, Content, Elsevier Business Intelligence; (moderator), Editor-in-Chief, Elsevier Business Intelligence; Venture Partner, Imperial Innovations; , CEO, The Foundry; , CEO, APICA Cardiovascular; , CEO, i360 Medical.
These interviews will be featured post-conference at , to which a link will be provided to participating companies for their unrestricted use; availability of these video interviews will be broadly promulgated within the medtech industry. All one-on-one interviews with presenting-company CEOs will take place at, and during the IN3 Dublin conference and be organized by , President of Ronald Trahan Associates, Inc. To schedule the free on-camera interviews contact , or call +1-508-359-4005, x108.
IN3 Dublin will feature presentations by early development- to commercial-stage start-up device companies seeking funding and/or strategic partnership. Confirmed presenters to date include: Access Bio, Aerogen, Aleva Neurotherapeutics, AltaScience, APICA Cardiovascular, Calon Cardio-Technology, CapeRay, Chronix Biomedical, Crescent Diagnostics, Dialog Devices, Expanding Orthopedics, FBC Device, Glysure, Humedics, i360medical, Infandx, Life Care Medical Devices, Mainstay Medical, Mederi Therapeutics, MedLumics, Miracor Medical Systems, Nano Bridging Molecules, Neuravi, NeuroMed Devices, Nordocs, Novate Medical, Quanta Fluid Solutions, Regenesis Biomedical, Respinova, Revision Optics, ROWIAK, Simpirica Spine, SpineLab, Specialty Scanners, Technopath, Valtronic, Vascular Flow Technologies, Veryan Medical, and Vivasure Medical.
Event co-sponsors include , , , , , , , , , , . , and .
Visit for full conference and registration details. Emerging medtech companies that would like to apply to present in Dublin should contact at 949-797-7142, or email
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI () has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.
Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.04.2013 - 07:00 Uhr
Sprache: Deutsch
News-ID 1214114
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
DUBLIN, IRELAND
Phone:
Kategorie:
Commercial & Investment Banking
Anmerkungen:
Diese Pressemitteilung wurde bisher 140 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"At Investment-In-Innovation (IN3) Medical Device 360 Degrees Dublin, the Debate Will Continue: Should Medtech Companies Start-Up in the U.S. or Europe?
"
steht unter der journalistisch-redaktionellen Verantwortung von
Elsevier Business Intelligence (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
